Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.263,58
-0,34%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Myriad Genetics Inc (MYGN) Myriad Genetics Inc (MYGN) Notizie

Myriad Genetics Inc

MYGN
14,56
-0,09 (-0,61%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/2/202514:32EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
06/2/202514:30GLOBEMyriad Genetics and CancerCARE for Life Announce Agreement..
05/2/202522:15GLOBEMyriad Genetics Announces Two New Patents Granted for its..
05/2/202514:30GLOBEMyriad Genetics and Lumea Collaborate to Enhance Access to..
30/1/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202514:30GLOBEMyriad Genetics Unveils Groundbreaking Eight Weeks’..
23/1/202514:30GLOBEMyriad Genetics Introduces Online Prenatal Genetic Testing..
21/1/202514:30GLOBEMyriad Genetics Announces Hereditary Cancer Risk Assessment..
15/1/202514:39EDGAR2Form 8-K - Current report
15/1/202514:30GLOBEMyriad Genetics Announces Select Preliminary Fourth Quarter..
09/1/202522:30GLOBEMyriad Genetics Signs Agreement with Nationally Renowned..
08/1/202517:27GLOBEUPDATE – Myriad Genetics to Present at 43rd Annual J.P...
08/1/202514:00GLOBEMyriad Genetics to Present at 43rd Annual J.P. Morgan..
07/1/202514:00GLOBEMD Anderson and Myriad Genetics form strategic alliance to..
06/1/202514:00GLOBEMyriad Genetics Issues Quality, Innovation, and Corporate..
02/1/202522:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:15GLOBEMyriad Genetics’ RiskScore Study Named One of the Top 10..
12/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202400:26GLOBEMyriad Genetics Provides Update on Discussions with..
10/12/202422:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/12/202422:08EDGAR2Form 8-K - Current report
10/12/202422:05GLOBEMyriad Genetics Expands Board of Directors with Election of..
09/12/202422:05GLOBEMyriad Genetics to Present New Data at San Antonio Breast..
09/12/202414:00GLOBENCCN Prostate Cancer Guidelines Reinforce Status of Myriad..
02/12/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:42EDGAR2Form 8-K - Current report
20/11/202422:30GLOBEMyriad Genetics Announces Incorporation of its Proprietary..
19/11/202414:00GLOBEMyriad Genetics Announces Prequel® Prenatal Screening Can..
14/11/202422:16EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202414:00GLOBEMyriad Genetics Expands Access to At-Home Early Fetal Sex..
08/11/202414:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:11EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEMyriad Genetics Reports Third Quarter 2024 Financial..
04/11/202414:39GLOBEMyriad Genetics Comments on UnitedHealthcare’s Updated..
30/10/202413:00GLOBEMyriad Genetics to Release Third Quarter 2024 Financial..
16/10/202415:00GLOBEMyriad Genetics and jscreen™ Announce Strategic..
15/10/202415:00GLOBEMyriad Genetics and Flatiron Health Partner to Make Genetic..
11/10/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202416:35EDGAR2Form 144 - Report of proposed sale of securities
10/10/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202412:11EDGAR2Form 8-K - Current report
08/10/202422:05GLOBEMyriad Genetics Announces Five Research Collaborations to..
03/10/202415:00GLOBEMyriad Genetics and Ultima Genomics to Explore the UG..
01/10/202422:05GLOBEMyriad Genetics Announces Third Patent Granted for Molecular..
23/9/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 14,79 Min: 14,44 Max: 14,98
Chiusura: 14,65

La tua Cronologia

NASDAQ
MYGN
Myriad Genetics
NASDAQ
DDOG
Datadog
NYSE
WFC-A
Wells Fargo
BIT
UC2BY4
Unicredit Bank
USOTC
ACNV
Accelera Innovations (CE)
NASDAQ
RCAT
Red Cat
USOTC
VNTRF
Venator Materials (CE)
BIT
P19FT2
BNP Paribas Issuance
BOV
BBAS3M
BANCO DO BRASIL ON
LSE
ZK02
Bbg Suk 29
LSE
0Q33
Velgraf Asset Management...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci